CSMD1 rs10503253增加了突尼斯人口群的精神分裂症风险
Ons Mihoub1, Arij Ben Chaaben2, Wahid Boukouaci3
1Laboratory of Human Genetics (LR99ES10), Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia; Inserm U955 IMRB, Translational Neuropsychiatry Laboratory and Paris-Est Créteil University, 94010 Créteil, France.
在CSMD1中的基因变异rs10503253和CFB中的基因变异rs1270942被研究了精神分裂症风险. rs10503253A等位基因与精神分裂症和症状严重程度有关,而rs1270942可能会改变疾病风险.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 精神病学是一个精神病学.
背景情况:
- 精神分裂症是一种复杂的神经精神疾病,具有已识别的遗传风险变体.
- 全基因组关联研究强调单核酸多态 (SNP) 如rs10503253 (CSMD1) 和rs1270942 (CFB) 作为潜在的风险因素.
研究的目的:
- 调查rs10503253和rs1270942变体与精神分裂症风险之间的关联.
- 评估这些遗传变异与突尼斯人口中精神分裂症疾病严重程度和临床特征之间的关系.
主要方法:
- 一项涉及216名精神分裂症患者和176名健康对照者的病例控制研究.
- 通过使用四元原料放大耐火突变系统-聚合酶连锁反应方法,对rs10503253和rs1270942多态的基因定型.
- 使用Compare V2.1软件和Kruskal-Wallis对相关性的测试进行统计分析.
主要成果:
- 在精神分裂症患者中,rs10503253A等位基因明显更频繁,并且与更高的负面PANSS分数相关.
- 没有发现rs1270942与精神分裂症风险有显著的关联,但它与更高的阳性PANSS分数有积极的相关性.
结论:
- 证实了CSMD1 rs10503253A等位基因与精神分裂症风险的关联.
- 识别了rs1270942变体作为精神分裂症疾病风险和严重程度的潜在修饰者.
- 表明这些遗传发现对于理解北非人口面临精神疾病风险的免疫遗传背景的重要性.
更多相关视频
09:52Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
相关概念视频
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychological and Sociocultural Causes of Schizophrenia
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
